Oncolytics Biotech Inc
(ONCY)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2005 | 06-2005 | 03-2005 | 12-2004 | 09-2004 | |
| Sales | 211 | 137 | 245 | 220 | 194 |
| Gross Profit | 210 | 160 | 240 | 220 | 190 |
| Operating Expenses | 3,610 | 3,030 | 2,590 | 4,110 | 3,030 |
| Operating Income | -3,399 | -2,893 | -2,345 | -3,890 | -2,836 |
| Other Income | -111 | -57 | -25 | -110 | -254 |
| Pre-tax Income | -3,510 | -2,950 | -2,370 | -4,000 | -3,090 |
| Net Income Continuous | -3,510 | -2,403 | 2,377 | -4,000 | -3,096 |
| Net Income | $-3,510 | $-2,403 | $2,377 | $-4,000 | $-3,096 |
| EPS Basic Total Ops | -1.04 | -0.66 | 0.66 | N/A | -1.04 |
| EPS Basic Continuous Ops | -1.04 | -0.69 | 0.70 | N/A | -1.00 |
| EPS Diluted Total Ops | -1.04 | -0.66 | 0.66 | N/A | -1.04 |
| EPS Diluted Continuous Ops | -1.04 | -0.69 | 0.70 | N/A | -1.00 |
| EBITDA(a) | $-3,199 | $-2,663 | $-2,145 | $-3,690 | $-2,646 |